Download Network-based Identification and Prioritization of Key Regulators of

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Long non-coding RNA wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Behavioural genetics wikipedia , lookup

Gene therapy wikipedia , lookup

Epistasis wikipedia , lookup

Gene desert wikipedia , lookup

Population genetics wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Human genetic variation wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Genetic engineering wikipedia , lookup

Pathogenomics wikipedia , lookup

Minimal genome wikipedia , lookup

Ridge (biology) wikipedia , lookup

Gene wikipedia , lookup

Gene expression programming wikipedia , lookup

Genomic imprinting wikipedia , lookup

History of genetic engineering wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Epigenetics of human development wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Genome evolution wikipedia , lookup

RNA-Seq wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Gene expression profiling wikipedia , lookup

Microevolution wikipedia , lookup

Designer baby wikipedia , lookup

Quantitative trait locus wikipedia , lookup

Biology and consumer behaviour wikipedia , lookup

Genome (book) wikipedia , lookup

Public health genomics wikipedia , lookup

Transcript
Network-based Identification and Prioritization of Key Regulators of Coronary Artery
Disease Loci
Yuqi Zhao, UCLA, Los Angeles, CA; Jing Chen, Johannes M Freudenberg, GSK, Collegeville,
PA; Qingying Meng, UCLA, Los Angeles, CA; CARDIoGRAM Consortium; Deepak K Rajpal,
GSK, Collegeville, PA; Xia Yang, UCLA, Los Angeles, CA
Objective: Recent genome-wide association studies (GWAS) of coronary artery disease (CAD)
have revealed 58 genome-wide significant and 148 suggestive genetic loci. However, the
molecular mechanisms through which they contribute to CAD and the clinical implications of
these findings remain largely unknown. We aim to retrieve gene subnetworks of the 206 CAD
loci and identify and prioritize candidate regulators to better understand the biological
mechanisms underlying the genetic associations.
Approach and Results: We devised a new integrative genomics approach that incorporated i)
candidate genes from the top CAD loci, ii) the complete genetic association results from the
CARDIoGRAM-C4D CAD GWAS, iii) tissue-specific gene regulatory networks that depict the
potential relationship and interactions between genes, and iv) tissue-specific gene expression
patterns between CAD patients and controls. The networks and top ranked regulators according
to these data-driven criteria were further queried against literature, experimental evidence, and
drug information to evaluate their disease relevance and potential as drug targets. Our analysis
uncovered several potential novel regulators of CAD such as LUM and STAT3, which possess
properties suitable as drug targets. We also revealed molecular relations and potential
mechanisms through which the top CAD loci operate. Furthermore, we found that extracellular
matrix genes coordinate multiple CAD-relevant biological processes such as complement and
coagulation cascades and lipid metabolism through tissue-specific interactions in the CAD
networks.
Conclusion: Our data-driven integrative genomics framework unraveled tissue-specific
relations among the candidate genes of the CAD GWAS loci and prioritized novel network
regulatory genes orchestrating biological processes relevant to CAD.
Disclosure Block:
Y. Zhao: None. J. Chen: None. J.M. Freudenberg: None. Q. Meng: None. D.K. Rajpal:
None. X. Yang: None.